Mechanisms of renal sympathetic activation in renovascular hypertension

Experimental Physiology

Volumn 100, Issue 5, 2015, Pages 496-501

  Campos, Ruy R ^a   Oliveira Sales, Elizabeth Barbosa ^a   Nishi, Erika E ^a   Paton, Julian F R ^b   Bergamaschi, Cassia T ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ASCORBIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME SUBUNIT; GENE EXPRESSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; ROSTRAL VENTROLATERAL MEDULLA; SHAM PROCEDURE; SYMPATHETIC FUNCTION; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; DRUG EFFECTS; HUMAN; INNERVATION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; OXIDATIVE STRESS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84929658624     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.079855     Document Type: Article

References (35)

1. Bergamaschi C, Campos RR, Schor N & Lopes OU (1995). Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension. Hypertension 26, 1117-1120.
2. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR & Bakris GL; SYMPLICITY HTN-3 Investigators (2014). A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370, 1393-1401.
3. Biancardi VC, Son SJ, Ahmadi S, Filosa JA & Stern JE (2014). Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 63, 572-579.
4. Dampney RAL, Horiuchi J, Killinger S, Sheriff MJ, Tan PS & McDowall LM (2005). Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol 32, 419-425.
5. 1R and iNOS in the rostral ventrolateral medulla (RVLM) is essential for the sympathetic hyperactivity and hypertension in the 2K-1C Wistar rat model. Am J Hypertens 23, 708-715.
6. DiBona GF & Kopp UC (1997). Neural control of renal function. Physiol Rev 77, 75-197.
7. Esler M (2010). The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 108, 227-237.
8. Esler M, Lambert E & Schlaich M (2010). Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol 109, 1996-1998; discussion 2016.
9. Ferguson AV & Washburn DL (1998). Angiotensin II: a peptidergic neurotransmitter in central autonomic pathways. Prog Neurobiol 54, 169-192.
10. 1A receptor antisense lowers blood pressure in acute 2-kidney, 1-clip hypertension. Hypertension 38, 674-678.
11. Goldblatt H, Lynch J, Hanzal RF & Summerville WW (1934). Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59, 347-379.
12. Grimson KS (1941). Total thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg 114, 753-775.
13. Guo F, Liu B, Tang F, Lane S, Souslova EA, Chudakov DM, Paton JFR & Kasparov S (2010). Astroglia are a possible cellular substrate of angiotensin(1-7) effects in the rostral ventrolateral medulla. Cardiovasc Res 87, 578-584.
14. Guyenet PG (2006). The sympathetic control of blood pressure. Nat Rev Neurosci 7, 335-346.
15. Guyton AC (1990). Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Physiol Regul Integr Comp Physiol 259, R865-R877.
16. Jancovski N, Carter DA, Connelly AA, Stevens E, Bassi JK, Menuet C & Allen AM (2014). Angiotensin type 1A receptor expression in C1 neurons of the rostral ventrolateral medulla contributes to the development of angiotensin-dependent hypertension. Exp Physiol 99, 1597-1610.
17. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G & Friberg P (1999). Increased sympathetic nerve activity in renovascular hypertension. Circulation 99, 2537-2542.
18. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R & Esler MD (2014). Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 383, 622-629.
19. Nishi EE, May CN, Campos RR, Bergamaschi CT & Yao ST (2014). Blood-brain barrier leakage in the paraventricular nucleus of the hypothalamus of renovascular hypertensive rats. Hypertension 63, E155.
20. Nishi EE, Oliveira-Sales EB, Bergamaschi CT, Cesar Oliveira TG, Boim MA & Campos RR (2010). Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. Am J Hypertens 23, 473-480.
21. Oliveira-Sales EB, Colombari DS, Davisson RL, Kasparov S, Hirata AE, Campos RR & Paton JFR (2010). Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 56, 290-296.
22. Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, D'Almeida V, Dolnikoff MS, Bergamaschi CT & Campos RR (2008). Oxidative stress contributes to renovascular hypertension. Am J Hypertens 21, 98-104.
23. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT & Campos RR (2009). Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 22, 484-492.
24. Oliveira-Sales EB, Toward MA, Campos RR & Paton JFR (2014). Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. Auton Neurosci 183, 23-29.
25. Paton JFR, Deuchars J, Ahmad Z, Wong LF, Murphy D & Kasparov S (2001). Adenoviral vector demonstrates that angiotensin II-induced depression of the cardiac baroreflex is mediated by endothelial nitric oxide synthase in the nucleus tractus solitarii of the rat. J Physiol 531, 445-458.
26. Paton JFR, Kasparov S & Paterson DJ (2002). Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci 25, 626-631.
27. Paton JFR, Waki H, Abdala AP, Dickinson J & Kasparov S (2007). Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide. Curr Hypertens Rep 9, 242-247.
28. Paul M, Poyan Mehr A & Kreutz R (2006). Physiology of local renin-angiotensin systems. Physiol Rev 86, 747-803.
29. Smithwick RH (1940). The problem of producing complete and lasting sympathetic denervation of the upper extremity by preganglionic section. Ann Surg 112, 1085-1100.
30. Song K, Allen AM, Paxinos G & Mendelsohn FA (1992). Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol 316, 467-484.
31. 1 receptors in the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 293, R2267-R2278.
32. Xue B, Zhang Z, Johnson RF & Johnson AK (2012). Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment. Hypertension 59, 459-466.
33. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR & Davisson RL (2002). Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91, 1038-1045.
34. Zimmerman MC, Lazartigues E, Sharma RV & Davisson RL (2004). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95, 210-216.
35. Zucker IH, Xiao L & Haack KK (2014). The central RAS and sympathetic nerve activity in chronic heart failure. Clin Sci (Lond) 126, 695-706.